Forough Yousefi

Forough Yousefi

Auto-generated profile, based on publicly available information

Forough Yousefi

Department of Microbiology and Parasitology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Natural Product Communications
Verified
Journal Article
Open access
PDF file
KZKeivan Zandi
Keivan Zandi
ERElissa Ramedani
Elissa Ramedani
KMKhosro Mohammadi
Khosro Mohammadi
STSaeed Tajbakhsh
Saeed Tajbakhsh
IDIman Deilami
Iman Deilami
FFFatemeh Farshadpour
Fatemeh Farshadpour
Antiviral drug resistance is one of the most common problems in medicine, and, therefore, finding new antiviral agents, especially from natural resources, seems to be necessary. This study was designed to assay the antiviral activity of curcumin and its new derivatives like gallium-curcumin and Cu-curcumin on replication of HSV-1 in cell culture. The research was performed as an in vitro study in which the antiviral activity of different concentrations of three substances including curcumin, Gallium-curcumin and Cu-curcumin were tested on HSV-1. The cytotoxicity of the tested compounds was also evaluated on the Vero cell line. The CC50 values for curcumin, gallium-curcumin and Cu-curcumin were 484.2 μg/mL, 255.8 μg/mL and 326.6 μg/mL, respectively, and the respective IC50 values 33.0 μg/mL, 13.9 μg/mL and 23.1 μg/mL. The calculated SI values were 14.6, 18.4 and 14.1, respectively. The results showed that curcumin and its new derivatives have remarkable antiviral effects on HSV-1 in cell culture.

18 July 2024 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
SRSepideh Rezaei
Sepideh Rezaei
STSaeed Tajbakhsh
Saeed Tajbakhsh
BNBehrouz Naeimi
Behrouz Naeimi
FYForough Yousefi
Forough Yousefi
Background: The emergence of fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae is a growing concern. To investigate the mechanisms behind this resistance, we studied a total of 215 K. pneumoniae isolates from hospitals in Bushehr province, Iran, collected between 2017 and 2019. Antimicrobial susceptibility test for fluoroquinolones was determined. The presence of plasmid mediated quinolone resistance (PMQR) and mutations in quinolone resistance-determining region (QRDR) of gyrA and parC genes in ciprofloxacin-resistant K. pneumoniae isolates were identified by PCR and sequencing. Results: Out of 215 K. pneumoniae isolates, 40 were resistant to ciprofloxacin as determined by E-test method. PCR analysis revealed that among these ciprofloxacin-resistant isolates, 13 (32.5%), 7 (17.5%), 40 (100%), and 25 (62.5%) isolates harbored qnrB, qnrS, oqxA and aac(6’)-Ib-cr genes, respectively. Mutation analysis of gyrA and parC genes showed that 35 (87.5%) and 34 (85%) of the ciprofloxacin-resistant isolates had mutations in these genes, respectively. The most frequent mutations were observed in codon 83 of gyrA and codon 80 of parC gene. Single gyrA substitution, Ser83→ Ile and Asp87→Gly, and double substitutions, Ser83→Phe plus Asp87→Ala, Ser83→Tyr plus Asp87→Ala, Ser83→Ile plus Asp87→Tyr, Ser83→Phe plus Asp87→Asn and Ser83→Ile plus Asp87→Gly were detected. In addition, Ser80→Ile and Glu84→Lys single substitution were found in parC gene. Conclusions: Our results indicated that 90% of isolates have at least one mutation in QRDR of gyrA orparC genes, thus the frequency of mutations was very significant and alarming in our region.

1 March 2009 in Acta Microbiologica Et Immunologica Hungarica
Verified
Journal Article
Closed access
BBBibi Sedigheh Fazly Bazzaz
Bibi Sedigheh Fazly Bazzaz
MNMahboobeh Naderinasab
Mahboobeh Naderinasab
AMAmir Mohamadpoor
Amir Mohamadpoor
ZFZahra Farshadzadeh
Zahra Farshadzadeh
SASamaneh Ahmadi
Samaneh Ahmadi
FYForough Yousefi
Forough Yousefi
This study was conducted at a 900+ bed general teaching hospital, from May to September 2007, in Iran. The aim of this study was to determine the prevalence of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae and their antimicrobial pattern. The Kirby-Bauer disk diffusion method and the phenotypic disk confirmatory test were performed for each isolate. The total of 206 isolates including 106 E. coli and 100 K. pneumoniae were collected of which 122 isolates (59.2%) were ESBL positive. The prevalence of ESBL-producing strains was 59.2% (122/206). All the isolates were susceptible to imipenem. Among the ESBL-producing isolates, the sensitivity was from 3.3% to 61.5% for ampicillin to aztreonam. From female isolates (136), 59.5% and from male isolates (70), 58.6% were ESBL-producers. Ratios of isolates from hospitalized patients to out-patients were 94/28 in the ESBL-producing group. The number of ESBL-producing isolates according to the isolation sites showed a significant difference between ESBL-producers and non-producers in blood samples (P < 0.05). This study shows that the prevalence of ESBL strains in Iran is high. It seems necessary for clinicians and medical community personnel to be fully aware of ESBL-producing microorganisms.

1 August 2010
Verified
Journal Article
Closed access
KZKeivan Zandi
Keivan Zandi
SAS Ahmadzadeh
S Ahmadzadeh
STS Tajbakhsh
S Tajbakhsh
ZRZ Rastian
Z Rastian
FYF Yousefi
F Yousefi
KSK Sartavi
K Sartavi

10 March 2015 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
FYForough Yousefi
Forough Yousefi
SMSeyed fazlollah Mousavi
Seyed fazlollah Mousavi
SSSeyed Davar Siadat
Seyed Davar Siadat
MAMohammad Mehdi Aslani
Mohammad Mehdi Aslani
JAJafar Amani
Jafar Amani
AIAbbas Ali Imanifooladi
Abbas Ali Imanifooladi
Tumor-targeted superantigens (TTSs) have been used to treat a variety of tumors in preclinical studies. The TTS utilizes the powerful T-cell activation strategy by means of staphylococcal enterotoxins (SEs) as superantigens (Sags) to target tumor cells. Monoclonal antibodies and tumor-related ligands have been used as targeting molecules of Sag. In this study, we assessed the antitumor potency of tumor-targeted superantigen (TTS) strategy to design and produce fusion protein as a new antitumor candidate. The third loop (L3) of transforming growth factor α (TGF-α) was genetically conjugated to staphylococcal enterotoxin type B (TGFαL3-SEB), and its in vitro antitumor activity against murine breast cancer cells (A431 cell line) was evaluated. We designed and prepared TGFαL3-SEB chimeric protein and evaluated superantigenic activity, binding property to cancer cells, overexpression of epidermal growth factor receptor (EGFR), and in vitro antitumor activities. Cloning of tgfαl3-seb was confirmed by colony-polymerase chain reaction, enzymatic digestion, and sequencing. The recombinant TGFαL3-SEB fusion protein with molecular weight of 31 kDa was expressed and confirmed by anti-His Western-blot analysis. The TGFαL3-SEB fusion protein attached to A431 cell line with proper affinity and induced dose-dependent cytotoxicity against EGFR-expressing cancer cells in vitro. The TGFαL3-SEB chimeric protein exhibited potent in vitro antitumor activity. Our findings indicated that TGFαL3-SEB may be a promising anticancer candidate in cancer immunotherapy, and further studies are required to explore its potential in vivo therapeutic applications.

11 November 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
FYForough Yousefi
Forough Yousefi
SSSeyed Davar Siadat
Seyed Davar Siadat
ASAlireza Azizi Saraji
Alireza Azizi Saraji
SHSaeed Hesaraki
Saeed Hesaraki
MAMohammad Mehdi Aslani
Mohammad Mehdi Aslani
AIAbbas Ali Imanifooladi
Abbas Ali Imanifooladi